Difference between revisions of "Adverse drug event"
From Clinfowiki
| Line 18: | Line 18: | ||
* [[Drug-laboratory interaction]] | * [[Drug-laboratory interaction]] | ||
* [[Drug-tobacco interaction]] | * [[Drug-tobacco interaction]] | ||
| + | |||
| + | == Reviews == | ||
| + | |||
| + | [[Risk factors for adverse drug events]] | ||
== References == | == References == | ||
# What is a Serious Adverse Event? FDA. [http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm] | # What is a Serious Adverse Event? FDA. [http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htm] | ||
Revision as of 22:18, 4 September 2014
An adverse event (ADE) is any undesirable experience associated with the use of a medical product in a patient. The event is serious and should be reported to U.S. Food and Drug Administration (FDA) when the patient outcome is:
- Death
- Life-threatening
- Congenital Anomaly/Birth Defect
- Required Intervention to Prevent Permanent Impairment or Damage (Devices)
- Other Serious (Important Medical Events)
Clinical Decision Support
Rules for ADE are often used in clinical decision support systems.
Important interactions
- Drug-drug interaction
- Drug-allergy interaction
- Drug-food interaction
- Drug-laboratory interaction
- Drug-tobacco interaction
Reviews
Risk factors for adverse drug events
References
- What is a Serious Adverse Event? FDA. [1]
